Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastomaDeepak Rohila(University of California San Diego), Shweta Joshi(University of California San Diego)Frontiers in ImmunologyJune 7, 202310.3389/fimmu.2023.1148317Cited by 17SaveCiteExport RISWatch citationsRelated PapersSyk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma|Cancer Research|2023|42